Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 624 for UniProtKB: P05121
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM92479(Tannic Acid, A | Tannic acid)
Affinity DataIC50:  7nMpH: 7.8 T: 23°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM92485(CDE-066 | US9120744, CDE-066)
Affinity DataIC50:  10nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132855(1-{3-[2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexy...)
Affinity DataIC50:  10nMAssay Description:Plasminogen Activator Inhibitor-1 (PAI-1) activity was determined using plasma clot lysis assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132862(4-{3-[2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexy...)
Affinity DataIC50:  10nMAssay Description:Plasminogen Activator Inhibitor-1 (PAI-1) activity was determined using plasma clot lysis assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175525(US9120744, CDE-001 (or 073))
Affinity DataIC50:  10nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175528(US9120744, CDE-004)
Affinity DataIC50:  10nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175527(US9120744, CDE-003)
Affinity DataIC50:  10nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175526(US9120744, CDE-002)
Affinity DataIC50:  10nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

LigandPNGBDBM264615(US9718760, C182)
Affinity DataIC50:  33nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

LigandPNGBDBM264650(US9718760, C204)
Affinity DataIC50:  35nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127745((E)-3-[3-(4-Chloro-phenoxy)-5,6-bis-(4-phenylsulfa...)
Affinity DataIC50:  39nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175544(US9120744, CDE-058)
Affinity DataIC50:  50nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175546(US9120744, CDE-061)
Affinity DataIC50:  50nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

LigandPNGBDBM264630(US9718760, C198)
Affinity DataIC50:  51nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175558(US9120744, CDE-075)
Affinity DataIC50:  70nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM175548(US9120744, CDE-059)
Affinity DataIC50:  90nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50070942((-)-Epigallocatechin gallate | (-)-Epigallocatechi...)
Affinity DataIC50:  91nMpH: 7.8 T: 23°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132853(3-{3-[2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexy...)
Affinity DataIC50:  100nMAssay Description:Plasminogen Activator Inhibitor-1 (PAI-1) activity was determined by inhibition of Urokinase-type plasminogen activator using primary assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132856(3-Hydroxy-4-[(4-{[2-((1R,2S,5R)-2-isopropyl-5-meth...)
Affinity DataIC50:  100nMAssay Description:Plasminogen Activator Inhibitor-1 (PAI-1) activity was determined using plasma clot lysis assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127735((E)-3-[3-(4-Chloro-phenoxy)-5,6-bis-(4-phenoxy-ben...)
Affinity DataIC50:  100nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127733((E)-3-[5,6-Bis-(biphenyl-4-ylmethoxy)-3-phenoxy-be...)
Affinity DataIC50:  100nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM264611(US9718760, C188)
Affinity DataIC50:  120nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127743((E)-3-[5,6-Bis-(biphenyl-4-ylmethoxy)-3-(4-chloro-...)
Affinity DataIC50:  130nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127732((E)-3-[3-(4-Chloro-phenoxy)-5,6-bis-(4'-methoxy-bi...)
Affinity DataIC50:  140nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM264602(US9718760, C197)
Affinity DataIC50:  173nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

LigandPNGBDBM264616(US9718760, C183)
Affinity DataIC50:  180nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50104502(8-{4-[3,6-Dioxo-5-[1-{4-[(thiophene-2-carbonyl)-am...)
Affinity DataIC50:  200nMAssay Description:Inhibitory activity of compound against Plasminogen activator inhibitor-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50111316(8-[4-(3,6-Dioxo-5-{4-[(thiophene-2-carbonyl)-amino...)
Affinity DataIC50:  200nMAssay Description:Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127742((E)-3-[5,6-Bis-(biphenyl-3-ylmethoxy)-3-(4-chloro-...)
Affinity DataIC50:  220nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127726((E)-3-[5,6-Bis-(biphenyl-4-ylmethoxy)-3-(3-fluoro-...)
Affinity DataIC50:  240nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM264613(US9718760, C157)
Affinity DataIC50:  250nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50104502(8-{4-[3,6-Dioxo-5-[1-{4-[(thiophene-2-carbonyl)-am...)
Affinity DataIC50:  260nMAssay Description:Tissue plasminogen activator generation in plasmin was evaluated by measuring the ability to inhibit Plasminogen activator inhibitor-1 through fibrin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127730((E)-3-[5,6-Bis-(4-benzyl-benzyloxy)-3-(4-chloro-ph...)
Affinity DataIC50:  270nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM92487(CDE-031 | US9120744, CDE-031)
Affinity DataIC50:  280nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50310309(CHEMBL596879 | N-(3,4-dihydroxyphenylsulfonyl)-N-h...)
Affinity DataIC50:  284nMAssay Description:Inhibition of human recombinant PAI1 assessed as rate of AMC release after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM264609(US9718760, C163)
Affinity DataIC50:  288nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50111273(6-Benzo[b]thiophen-2-yl-4-hydroxy-2-oxo-1,2-dihydr...)
Affinity DataIC50:  290nMAssay Description:Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50111280(1-(4-Chloro-phenyl)-4-hydroxy-2-oxo-2,5-dihydro-1H...)
Affinity DataIC50:  300nMAssay Description:Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by complex assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50111298(8-{4-[(7-Benzo[b]thiophen-2-yl-4-hydroxy-2-oxo-1,2...)
Affinity DataIC50:  300nMAssay Description:Inhibitory activity against human plasminogen activator inhibitor-1(PAI-1) evaluated by chromogenic assay.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50116764(3-[1-Pyridin-2-yl-meth-(Z)-ylidene]-6-[1-[4-(3-pyr...)
Affinity DataIC50:  300nMAssay Description:Inhibitory concentration required against Plasminogen activator inhibitor 1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM92480(Epigallocatechin-3,5-Digallate, C)
Affinity DataIC50:  330nMpH: 7.8 T: 23°CAssay Description:Enzyme activity assay using human and murine PAI-1.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM264610(US9718760, C165)
Affinity DataIC50:  350nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM92482(CDE-008 | US9120744, CDE-008)
Affinity DataIC50:  370nMpH: 7.8 T: 23°CAssay Description:To determine the efficacy of various synthesized PAI-1 inhibitor compounds, a fluorometric plate assay was carried out to measure the half maximal in...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132862(4-{3-[2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexy...)
Affinity DataIC50:  380nMAssay Description:Plasminogen Activator Inhibitor-1 (PAI-1) activity was determined using plasma clot lysis assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132862(4-{3-[2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexy...)
Affinity DataIC50:  380nMAssay Description:Inhibitory concentration against plasminogen activator inhibitor-1 (PAI-1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50104505(9-{4-[3,6-Dioxo-5-[1-{4-[(thiophene-2-carbonyl)-am...)
Affinity DataIC50:  390nMAssay Description:Inhibitory activity of compound against Plasminogen activator inhibitor-1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50132853(3-{3-[2-((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexy...)
Affinity DataIC50:  400nMAssay Description:Plasminogen Activator Inhibitor-1 (PAI-1) activity was determined by inhibition of Urokinase-type plasminogen activator using primary assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM264645(US9718760, C185)
Affinity DataIC50:  420nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

LigandPNGBDBM264646(US9718760, C196)
Affinity DataIC50:  450nMpH: 7.4 T: 25°CAssay Description:To determine the efficacy of various synthesized compounds as PAI-1 inhibitors, a fluorometric plate assay was carried out to measure the half maxima...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetPlasminogen activator inhibitor 1(Human)
University of Michigan

LigandPNGBDBM50127741((E)-3-[5,6-Bis-benzyloxy-3-(4-chloro-phenoxy)-benz...)
Affinity DataIC50:  470nMAssay Description:Inhibitory activity against plasminogen activator inhibitor 1 (PAI-1) was evaluated by inhibition of tissue plasminogen activator/PAI-1 complex forma...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 624 total ) | Next | Last >>
Jump to: